Trial Profile

A Multicentric Clinical-Practice Based Cohort Study Evaluating Effectiveness And Identifying Predictors Of Response To Belimumab In Patients With Active Systemic lupus erythematosus (SLE)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 25 Jun 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 Jun 2019 Results assessing effectiveness and safety of belimumab,presented at the 20th Annual Congress of the European League Against Rheumatism.
24 Oct 2018 Results assessing safety and efficacy of response to belimumab in patients with active Systemic Lupus Erythematosus, presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
17 Jun 2017 Results (n=48) assessing the effect of belimumab treatment on skin involvement, presented at the 18th Annual Congress of the European League Against Rheumatism

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com